CN

Carina Namih

Founder and Investor

London, England

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

2022

  • Partner

    2022

    Plural is an early-stage investment fund that backs the most ambitious founders on a mission to change the world through technology. Our aim is to have GDP-level impact on Europe, address systemic risks and reduce the opportunity gap worldwide through the companies we back.

2013

  • Co-Founder, Board Member and former CEO

    2013

    HelixNano is an AI driven biotech developing next generation mRNA therapies.

  • Board Trustee

    2020

2021

  • Board Member

    2021

2020 - 2022

  • Board Member

    2020 - 2022

2020 - 2022

  • Board Member

    2020 - 2022

2020 - 2022

  • Board Member

    2020 - 2022

2019 - 2022

  • Board Member

    2019 - 2022

2019 - 2022

  • Board Member

    2019 - 2022

2018 - 2022

  • General Partner

    2018 - 2022